​

GT Biopharma Ownership | Who Owns GT Biopharma?

OverviewFinancialsChart

GT Biopharma Ownership Summary

100.00% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.51% of its assets in GT Biopharma shares.

GTBP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGT Biopharma--100.00%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20241-96.43%1-100.00%----100.00%1-75.00%
Dec 31, 202328-3.45%3,393,512-0.86%811.40%1330.00%4-50.00%
Sep 30, 202329-9.38%3,422,9683.35%811.87%10-8-11.11%
Jun 30, 202332-5.88%3,312,058-38.84%84.41%10-16.67%912.50%
Mar 31, 2023346.25%5,415,701-14.65%133.50%12-33.33%860.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index11.45K0.51%1.57K
Vanguard Institutional Extnd Mkt Idx Tr10.50K0.47%-
BlackRock Extended Equity Market K1.16K0.05%-
Fidelity Series Total Market Index1.15K0.05%-
Fidelity Nasdaq Composite Index1.02K0.05%-
Fidelity Total Market Index992.000.04%-
NT Ext Equity Mkt Idx Fd - NL604.000.03%-
NT Ext Equity Mkt Idx Fd - DC - NL - T2487.000.02%1.00
Spartan Total Market Index Pool E411.000.02%-
Northern Trust Extended Eq Market Idx389.000.02%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 11, 2023Breen Michael Martin Executive Chairman/Interim CEOBuy$25.00K
Apr 06, 2023Ohri Manu CFO & SecretaryBuy$25.00K
Dec 22, 2020Wendel Bruce-Buy$12.19K
Nov 16, 2020Wendel Bruce-Buy$10.26K
Dec 22, 2020Wendel Bruce-Buy$3.85K

Insider Transactions Trends

DateBuySell
2023 Q22-
2023 Q1--
2022 Q3--
2022 Q2--
2022 Q1--

GTBP Ownership FAQ

Who Owns GT Biopharma?

GT Biopharma shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in GT Biopharma's industry, Biotech Stocks , is 47.04%, which GT Biopharma falls below.

Does Blackrock own GT Biopharma?

BlackRock is not among the top 10 institutional shareholders of GT Biopharma.

Who is the top mutual fund holder of GT Biopharma shares?

Fidelity Extended Market Index is the top mutual fund holder of GT Biopharma shares, with 0.51% of its total shares outstanding invested in 11.45K GT Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools